Source:http://linkedlifedata.com/resource/pubmed/id/15768556
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-3-16
|
pubmed:abstractText |
Hb Riccarton was identified in a young boy under investigation for fatigue and microcytosis. However, the novel alpha51(CE9)Gly-->Ser mutation did not appear to be the cause of the microcytosis as it was also detected in the boy's father who had normal red cell indices.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0363-0269
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
61-4
|
pubmed:meshHeading |
pubmed-meshheading:15768556-Amino Acid Substitution,
pubmed-meshheading:15768556-Child, Preschool,
pubmed-meshheading:15768556-Glycine,
pubmed-meshheading:15768556-Hemoglobins, Abnormal,
pubmed-meshheading:15768556-Humans,
pubmed-meshheading:15768556-Male,
pubmed-meshheading:15768556-Point Mutation,
pubmed-meshheading:15768556-Serine
|
pubmed:year |
2005
|
pubmed:articleTitle |
Hb riccarton [alpha51(CE9)Gly-->Ser]: a variant arising from a novel mutation in the alpha1 gene.
|
pubmed:affiliation |
Molecular Pathology Laboratory, Canterbury Health Laboratories, Christchurch, New Zealand. steve.brennan@chmeds.ac.nz
|
pubmed:publicationType |
Journal Article
|